Exclusive: British Business Bank to back UK scaleups with £400m per year

2026-06-29 · Source: Sifted · Field: Finance & Economics — Capital Markets & Investment Management, Banking & Financial Services · Depth: Intermediate, short

Summary

The British Business Bank (BBB) intends to invest over £400m annually into UK scaleups, focusing on sectors like life sciences, deeptech, fintech, and clean energy. This initiative will involve writing initial cheques ranging from £10m to £40m for 10-12 companies each year, alongside potential follow-on investments up to £70m. This £400m direct investment is distinct from the £2m annual allocation to the UK's top 10 deep-tech VCs. Since its inception in 2014, the BBB has deployed £14.2bn into UK businesses, with this new funding forming part of a larger £250m fund, of which £150m has already been committed. BBB CEO Catherine Lewis La Torre highlighted a funding gap in the UK for larger growth rounds, which this program aims to address.

Key takeaway

For UK scaleup founders seeking significant growth capital, the British Business Bank's new £400m annual investment program presents a crucial opportunity. If your company operates in life sciences, deeptech, fintech, or clean energy and requires £10m-40m for expansion, you should actively engage with the BBB. This initiative directly addresses the identified funding gap for larger rounds, potentially reducing your reliance on overseas capital and accelerating your growth within the UK.

Key insights

The British Business Bank is deploying significant capital to bridge the UK's scaleup funding gap, particularly for larger growth rounds.

Principles

• State-backed investment can address market funding gaps for growth-stage companies.
• A robust early-stage ecosystem requires later-stage capital to prevent companies from relocating.

Method

The British Business Bank employs a direct investment strategy, providing initial cheques of £10m-40m and subsequent follow-on funding up to £70m to support scaleups.

In practice

• Target UK scaleups in life sciences, deeptech, fintech, and clean energy.
• Seek initial investments between £10m and £40m for growth-stage companies.

Topics

• British Business Bank
• UK Scaleups
• Venture Capital
• Deeptech
• Life Sciences
• Growth Capital

Best for: Entrepreneur, Investor, Policy Maker

Related on AIssential

• Exclusive: British Business Bank eyes stake in EU’s €5bn Scaleup Fund — The British Business Bank seeks a stake in the EU's €5bn Scaleup Fund, signaling a post-Brexit re-engagement with European investment.
• £100M boost for UK healthtech as British Business Bank backs Apposite growth fund — The British Business Bank has committed £100 million to Apposite Healthcare Growth I, marking its largest fund commitment to date and its first with specialist investor Apposite Capital.
• UK pension providers back £200m fund aimed at supercharging homegrown startups — UK pension funds are increasing venture capital allocations to boost domestic innovation and economic growth.
• Main Capital doubles down on enterprise software with €5.25 billion fund close — Main Capital Partners secured €5.25 billion to invest in enterprise software, focusing on AI-driven transformation and geographic expansion into the UK.
• Announcing the 2026 Built-On Databricks Startup Challenge — Databricks' startup challenge offers funding, credits, and exposure to B2B companies building on its platform.
• The Series B Pipeline Looks Refreshingly Diversified — Series B funding shows diversification beyond AI, increasing average round sizes, and stable round counts.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Sifted.